 |
We are collaborating with leading biotech researchers to develop a new
platform for the analysis of cellular physiology.
This platform identifies biologically relevant patterns in the complex data sets
produced by advanced proteomics, genomics, and metabolomics instruments.
|  |
|
proteomics, biomarkers, and diagnosis
|
|
Insilicos analyzes biology, primarily with pattern recognition, to determine the differences between health and disease. A method for determining health vs. disease is called a biomarker. Biomarkers are used to diagnose disease and to determine if a patient is responding to a drug. Biomarkers are also used in drug research and other biological research to understand the behavior of biological systems.
Insilicos concentrates on in vitro biomarkers. The patient supplies a small amount of a bodily fluid, such as blood. The blood is then analyzed, typically with a technique called mass spectrometry. Normally, most of the information produced is about the patient's proteins, so this approach is called proteomics.
A list of poster presentations is available.
|
 |